Fish oil
- Generic Name
- Fish oil
- Brand Names
- Omegaven
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- XGF7L72M0F
- Background
Fish oil is a component of SMOFLIPID, which was FDA approved in July 2016. It is indicated in adults as a source of calories and essential fatty acids for parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated.
...
- Indication
Under FDA approval, fish oil pharmaceuticals are typically products consisting of a combination of the omega-3-fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and are indicated primarily as an adjunct to diet to reduce triglyceride levels in adult patients with severe (>=500 mg/dL) hypertriglyceridemia .
...
- Associated Conditions
- -
- Associated Therapies
- Dietary and Nutritional Therapies, Nutritional supplementation, Parenteral Nutrition
Poly-unsaturated Fats for Improving Nasal Polyps and Asthma
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2023-12-04
- Target Recruit Count
- 98
- Registration Number
- NCT05613803
- Locations
- 🇬🇧
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, Norfolk, United Kingdom
Supplementation of n-3 PUFA in the Modulation of Lean Mass in Patients With Lung Cancer Receiving a High-protein Diet
- First Posted Date
- 2021-07-16
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- Universidade Federal do Rio de Janeiro
- Target Recruit Count
- 50
- Registration Number
- NCT04965129
- Locations
- 🇧🇷
Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil
Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2021-06-11
- Lead Sponsor
- Children's Mercy Hospital Kansas City
- Target Recruit Count
- 2
- Registration Number
- NCT04697888
- Locations
- 🇺🇸
Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States
High Dose Intravenous Fish Oil Reduces Inflammation
- First Posted Date
- 2020-07-10
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- Stanley Dudrick's Memorial Hospital
- Target Recruit Count
- 51
- Registration Number
- NCT04467138
- Locations
- 🇵🇱
Stanley Dudrick's Memorial Hospital, Skawina, Poland
Effects of Vitamin D and Omega-3 Supplementation on Telomeres in VITAL
- First Posted Date
- 2020-05-13
- Last Posted Date
- 2020-05-13
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 1054
- Registration Number
- NCT04386577
- Locations
- 🇺🇸
Georgia Prevention Institute, Augusta, Georgia, United States
Effects of Vitamin D and Omega-3 on Cerebrovascular Disease
- Conditions
- Interventions
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2022-08-15
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 290
- Registration Number
- NCT04070833
Omegaven as Alternative Parenteral Fat Nutrition
- First Posted Date
- 2018-09-07
- Last Posted Date
- 2020-07-22
- Lead Sponsor
- University of South Florida
- Target Recruit Count
- 2
- Registration Number
- NCT03662282
- Locations
- 🇺🇸
USF Health, Tampa, Florida, United States
Dietary Supplementation With Omega-3 Fatty Acid in Muscle Response
- First Posted Date
- 2018-03-13
- Last Posted Date
- 2018-05-04
- Lead Sponsor
- Eduardo Ferriolli
- Target Recruit Count
- 30
- Registration Number
- NCT03462771
- Locations
- 🇧🇷
Clinics Hospital of the Ribeirao Preto Medical School Ribeirão Preto, Ribeirão Preto, SP, Brazil
Omega 3 Fatty Acid Treatment for Pediatric Musculoskeletal Health
- First Posted Date
- 2017-04-25
- Last Posted Date
- 2019-09-16
- Lead Sponsor
- Boston Children's Hospital
- Registration Number
- NCT03127345
Fish Oil to Reduce Tobacco Use iN Expectant Mothers Study
- Conditions
- Interventions
- First Posted Date
- 2017-03-13
- Last Posted Date
- 2019-01-09
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 28
- Registration Number
- NCT03077724
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.